Navigation Links
Varian Medical Systems' ARIA Ranked No. 1 in 2011 KLAS Report on Oncology IT Vendors

PALO ALTO, Calif., Sept. 29, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) ranked first in overall performance among oncology information system vendors in a 2011 performance report released last month by KLAS, a research firm that specializes in monitoring and reporting on the performance of healthcare technology vendors.(1) Varian's ARIA® software, which is designed to manage a range of clinical, administrative, and financial activities in the multidisciplinary cancer treatment setting, rose by eight percentage points above its 2010 score, capturing the top spot for 2011.

"Varian is proud to have ranked number one in KLAS's annual survey for three out of four years," said Dow Wilson, president of Varian's Oncology Systems business.(2)  "We were particularly gratified this year to see that 94 percent of the customers surveyed would buy ARIA again, and 96 percent see ARIA as part of their long-term plans."

According to KLAS's Oncology IS 2011 report, Varian was the only vendor of the three analyzed to show upward momentum by registering a positive one-year trend.  Competitors showed no significant changes in ranking levels.  KLAS researchers interviewed 50 Varian customers at 45 distinct treatment center sites to generate the data used in the report.

"Varian has improved across the board, and customers are taking notice," said Monique Rasband, author of the report.  "Customers like the end-to-end workflow capability for oncology and the fact that integration is being built into the software upgrades.  ARIA's ease of use is also a highlight."

Some of the indicators for which Varian achieved top scores included: quality of implementation, product response time (tied for highest score), supports integration goals, executive involvement, overall communication, and forecasted overall satisfaction.

"We're gratified to receive top marks in this objective survey," said Wilson. "As a company committed to providing cancer treatment professionals with oncology-specific EMR technology to help them manage their practices, our customers' perceptions of our performance is of the utmost importance to us."

Varian will be showcasing the latest release of the ARIA program in the company's booth at the annual meeting of the American Society of Radiation Oncology (ASTRO) taking place next week in Miami Beach, Florida, featuring more personalization to the user, easy-to-follow task-driven workflows, greater automation, and a single clinical management system that accesses both ARIA and Varian's Eclipse™ treatment planning system from a single unified dashboard.

About KLAS

KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to, e-mail, or call 1-800-920-4109 to speak with a KLAS representative. ©2011 KLAS Enterprises, LLC. All rights reserved.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit or follow us on Twitter.

1. "Oncology IS 2011: Integrating the Island," August, 2011. © 2011 KLAS Enterprises, LLC. All rights reserved.

2. Varian's ARIA software ranked #1 in KLAS's annual survey in 2008, 2009, and 2011.

Meryl Ginsberg, (650) 424-6444

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Schedules Fourth Quarter FY2011 News Release and Conference Call
2. Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy
3. Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility
4. Varian Medical Systems Schedules Investor Meeting at ASTRO in Miami Beach, FL
5. Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems
6. Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
7. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
8. South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems
9. Varian Medical Systems to Offer CIVCO Medical Solutions Body Pro-Lok™ for SBRT
10. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2011
11. Scottish Executive Awards Varian Medical Systems Major Contract to Supply Advanced Radiotherapy Equipment to Scotlands Five Cancer Centers
Post Your Comments:
(Date:12/1/2015)... 1, 2015 --> ... report "Nucleic Acid Labeling Market by Product (Reagents & ... Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by ... The global market is expected to reach USD 1,925.7 ... growing at a CAGR of 8.65%. Browse ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... ... , ... Growth in medical payments per workers’ compensation claim in Louisiana slowed ... nonhospital care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... medical payments per claim with more than seven days of lost time continued to ...
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced ... Bridge Business Awards under the New Products and Services category for its innovative ... sample management software that helps labs organize data and track samples with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
Breaking Medicine News(10 mins):